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Médecine Orale / Oral Medicine

EWING’S SARCOMA OF THE MANDIBLE:
A CASE REPORT
Bhandarkar Gowri Pandarinath* | Shetty Kushal**
Abstract
Ewing’s sarcoma of the jaw is a primitive malignant tumor of the bone. It is commonly seen in children and adolescents. Its occurrence in the head and neck region is unusual and generally involves most frequently the mandible rather than the maxilla. The present
case discuss the clinical, diagnostic (radiographic, histopathologic) and therapeutic findings of an ES of the mandible in a 14-year-old
boy. Early detection of such lesions is difficult because the signs and the symptoms do not appear until the lesion has progressed
considerably. This case elucidates the importance of professional knowledge of the relevant aspects of malignant lesions such as
Ewing’s sarcoma.
Keywords: Ewing’s sarcoma – mandible – diagnosis – immunohistochemistry.
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SARCOME D’EWING AU NIVEAU DE LA MANDIBULE: À PROPOS
D’UN CAS
Résumé
Le sarcome d’Ewing de la mâchoire est une tumeur rare primitive et maligne de l’os. Il est communément observé chez les enfants et
les adolescents. Sa survenue au niveau de la région de la tête et du cou est inhabituelle et implique plus souvent la mandibule que le
maxillaire. Le cas présenté siège à la mandibule chez un garçon de 14 ans; les éléments cliniques, diagnostiques (radiographie, histopathologie) et thérapeutiques sont développés et discutés. La détection précoce de ces lésions est difficile car les signes et les
symptômes n’apparaissent que tardivement, après une progression considérable de la lésion. Ce cas révèle l’importance d’une
bonne connaissance des particularités des lésions malignes en général et du sarcome d’Ewing en particulier.
Mots-clés: sarcome d’Ewing – mandibule – diagnostic - immunohistochimie.
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Introduction
Ewing’s sarcoma (ES) was originally
described by James Ewing in 1921 as
arising from undifferentiated osseous
mesenchymal cells. Ewing stated that
the tumor was not associated with any
form of myeloma or osteogenic sarcoma and he thus termed it a “round
cell sarcoma”. However, recent studies suggest that Ewing’s tumor might
be neuro-ectodermally derived from
various degrees of differentiation of
the primitive neural tissues. Clinically,
this tumor has aggressive behaviour,
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characterized by rapid growth and high
probability of micrometastasis.
Approximately 80% of cases occur in
the first 2 decades of life [1] with a
2:1 male to female ratio. The majority
of the patients affected are between 5
and 20 years whereas it is rarely seen
before the age of 5 and after the age
of 30 years. It exhibits a marked predilection for Whites and is rarely seen
among Blacks. These lesions account
for 4-15% of all primary bone tumors
[2] and 1% of all malignant tumors in
children. 2/3 of all cases appear in the
lower skeleton [3] with a predisposition for long bones of the extremities

and the pelvis; the involvement of
facial skeleton is very rare (3%) [2], the
mandible being the most commonly
affected bone [4, 5].

Case Report
A 14-year-old boy visited the
Department of Oral Medicine and
Radiology at Bangalore Institute of
Dental Sciences, Bangalore, with a
chief complaint of a 6 months’ history of a painful, rapid, progressively
enlarging swelling in the right mandible associated with relapsing fever
at night. On clinical examination, the
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Fig.1a: Tumor of right mandible crossing the
midline to involve left parasymphysis
Fig. 1b: Tumor mass extending from right
retromolar area with displacement of teeth.

Fig. 2: Occlusal radiograph showing
labially displaced anterior teeth giving
floating teeth appearance.

patient was unable to close the mouth
with paresthesia of the lower 1/3rd of
the right side of the face (V3). Extraorally, the right side of the face was
grotesquely deformed with a diffuse,
hard fixed, expansive mass (Fig. 1a).
The tumor was extending superiorly up
to 2 cm below the ala- tragus line and
inferiorly below the inferior border of
the mandible involving the submandibular region. Anteriorly, the tumor was
extending up to the midline, crossing
it and reaching the opposite side of
the mandible up to the left parasymphyseal region. Posteriorly it extended
to the right angle of the mandible.
Overlying skin was distended and
slightly erythematous. The tumor was
hard to firm in consistency.

Fig. 3: The CT scan of the mandible revealed
the osteolytic lesion eroding the right side.

Intra-oral examination revealed an
expansile mass growing mainly against
the vestibular plate of the mandible,
infiltrating the gingiva and the floor
of the mouth. It was extending from
the right retromolar area to the left
mandibular premolars (Fig. 1b). The
tumor was submucosal, and obstructing occlusion of the dental arch with
displacement of the tongue to the left.
The overlying mucosa was distended
and erythematous. Ulceration was
noted in posterior areas. On palpation, the swelling was non-tender and
hard to firm in consistency. Bidigital
palpation revealed expansion of the
buccal cortical plate and perforation
of buccal and lingual cortex. Grade II
mobility and negative sensibility were

seen in the teeth from right mandibular second molars to left mandibular
lateral incisor. No significant palpable
lymph nodes were found in the neck.
Chest radiograph revealed no abnormal findings. Mandibular occlusal
radiograph showed poorly demarcated
destructive lesion with labially displaced anterior teeth (floating teeth
appearance) and eroded buccal and
lingual cortical plates (Fig. 2). CT scan
of the mandible revealed osteolytic
lesion eroding the mandibular bone
on its right side (Fig. 3).
Given the clinical and radiographic
findings, the differential diagnosis
included Ewing’s sarcoma, osteogenic sarcoma, rhabdomyosarcoma,
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Fig. 4: The tumour cells
arranged in diffuse sheets
and trabeculae separated by
fibroconnective septa.
The tumor cells
were round with round
nuclei, basophilic nucleoli
and granular cytoplasm.

Hodgkin’s lymphoma, non-Hodgkin’s
lymphoma and metastatic diseases.
Haematological and biochemical
investigations were within normal
limits except for thrombocytosis and
increased alkaline phosphatase levels.
Haematopathologic report of bone
marrow revealed no involvement of
marrow.
Under local anaesthesia, patient underwent an incisional biopsy. On histopathological microscopic examination,
H and E stained sections showed two
bits of infiltrating tumor tissue with
the tumor cells arranged in diffuse
sheets and trabeculae separated by
fibroconnective septa. The tumor cells
were predominantly round with round
nuclei, basophilic nucleoli and granular cytoplasm. Few hyperchromatic
cells with scanty cytoplasm were also
seen (Fig. 4). PAS stain was negative
for glycogen.
Immunohistochemistry was done and
the report revealed CK-focal positive;
CD20, CD3 and tdt and MPO were
negative. Desmin, Chromogranin and
Synaptophysin were also negative.
Mic2 showed membrane positivity.
These findings were consistent with
Ewing’s sarcoma of the mandible.
Cytogenetics was suggested and their
report revealed 46, XY, t(11,22) (q24,
q12). Other immunomarkers were all
negative. Histopathological, immunohistochemical and cytogenetical findings supported the diagnosis of ES.
The patient started a protocol consisting of antineoplastic agents: Vincristin

and Endoxan. After 2 months, the
patient underwent surgery with wide
resection of the affected area. Viable
tumor was present in the resected
mandible and all margins were negative. Histopathologic report confirmed
the diagnosis of Ewing’s sarcoma.
After the operation, the patient’s chemotherapy protocol was continued
for 4 months. The patient was lost for
follow-up.

Discussion
James Ewing first described Ewing’s
sarcoma (ES) in 1921, after observing
radiosensitivity in a subgroup of bone
tumors. Ewing’s sarcoma is the second
most common primary malignant
tumor of the bone in children and adolescents [2]. The site of predilection
is mostly the posterior regions with a
4:1 ratio compared to anterior regions
[3]. In the head and neck region, there
are non-specific clinical findings for
ES; most of the patient’s complaints
at time of presentation are due to
the mass effect of the tumor, its rapid
growth, the swelling of the affected
area and the pain sensation. When this
tumor arises in the mandible, other
signs and symptoms such as loosening
of the teeth, otitis and paraesthesia
may be observed. Systemic symptoms
such as fever, often remittent about 38
°C, weight loss and anemia can be also
noticed.
Ewing’s sarcoma is a poorly differentiated neurectodermal tumor with

small, round and blue cells [6]. More
than 90% of cases show a characteristic
translocation t(11;22) (q24;q12) resulting in the fusion of the EWS and FLI-1
genes [7]. This gene rearrangement
causes a fusion product which functions as an oncogenic aberrant transcription factor with structural variability and potentially prognostic impact.
Immmunoreactivity against FLI 1 and
CD99 can confirm the diagnosis [6].
The present case exhibited clinical
aspects similar to those reported in
the literature for cases in the head and
neck region: it was located in the mandible, displayed a rapidly progressive
growth and was accompanied by pain
and fever. This presentation is not specific, but it demands complementary
exams that can avoid large errors in
the diagnosis.
Radiographically, the lesion is poorly
defined, permeative, osteolytic and
may be frequently associated with
cortical erosion. This aspect is not
a pathognomonic feature, as other
lesions can have the same image
pattern such as osteogenic sarcoma,
neuroblastoma, lymphosarcoma, histiocytosis X, rhabdomyosarcoma, pyogenic osteomyelitis and metastatic
carcinoma [3]. The presence of “sunray” spicules of periosteal bone and
displacement or destruction of unerupted tooth follicles have been described as the commonest radiological
features for ES affecting jaw bones. But
some authors reported an occasional
“sun- ray” appearance [5, 8]. Further,
the presence of the laminar periosteal
response (known as “onion skin” reaction), pointed out by many authors as
a common radiological feature of ES
of the long bones, is rarely seen in the
jaw lesions [9]. In our case, neither
“sun-ray” spicules of periosteal bone
nor an “onion skin” reaction of cortical bone were observed. The osteolytic
lesion was associated with severe cortical erosion of the mandible.
Histologically, ES is composed of
small nucleoli and scanty cytoplasm.
The intra-cytoplasmic glycogen may
be demonstrated by PAS stain in 75%
of the cases. Biopsy is necessary to
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make a definitive diagnosis and the
tumor must be distinguished from
microscopically similar tumors and
conditions such as eosinophilic granuloma, malignant lymphoma, metastatic neuroblastoma and rhabdomyosarcoma [10]. Recent advances in
electron microscopy, immunohistochemical, cytogenetic and molecular
genetic techniques have increased the
accuracy of a differential diagnosis of
Ewing’s sarcoma. In our case, the use
of immunohistochemistry and cytogenetics helped in the diagnosis of this
tumor. In general, the tumor cells are
positive for Vimentin and CD99 and
negative for neural, skeletal, vascular
and lymphoid cell markers. Regarding
Mic2 antigen, recently published data
have confirmed the high sensitivity
of the Mic2 gene product (CD99) for
all ES family tumors with over 95%
of the cases showing positivity for
this marker. In fact, the expression of
CD99 protein is not conclusive to ES
because other round cell tumors, such
as Merkel cell carcinoma, small cell
osteosarcoma, T-lymphoblastic lymphoma and poorly differentiated synovial sarcoma may express this marker.
It has been reported that combined
therapy including surgery, radiothe-

rapy and chemotherapy is the best
approach for ES. The treatment should
include wide surgical resection and
neoadjuvant chemotherapy [6]. The
multidisciplinary treatment protocols have dramatically improved the
5-year survival rate of patients with ES
from less than 16% to more than 75%
of cases. Radiotherapy alone must be
undertaken only to treat non-resectable primary tumor or as an neoadjuvant therapy; chemotherapy alone also
helps suppressing potential micrometastasis and reducing the size of the
tumor prior to surgery. Radiotherapy
in doses greater than 4,000 cGy has
been effective in short-term control of
tumor growth in about 86% of cases
[11]. The chemotherapeutic agents
most commonly used are Vincristine,
Doxorubicine,
Cyclophosphamide,
Ifosfamide and Actinomycin-D.
Metastatic workup of Ewing’s sarcoma of the mandible should include
a chest computed tomography scan,
bone marrow aspirate and bone scan.
Ewing’s sarcoma is viewed as a systemic disease even when it is clinically
localized and current chemotherapy
regimens reflect this attitude [1].
Major prognostic factors include the
tumor site and its volume as well as

the presence of metastases. Tumors
arising in the jaw bones have better
prognosis than those located in long
bones. Younger children have better
event-free survival than older adolescents and young adults [12]. Clinical
features such as systemic symptoms
(fever, anaemia), high erythrocyte sedimentation rate, thrombocytosis and
elevated serum lactate dehydrogenase
levels are related to poor prognosis.
Increased serum lactate dehydrogenase levels prior to treatment correlate
with metastatic disease and shorter
disease-free survival [13].

Conclusion
The prognosis of ES is poor because
haematogenous spread and lung
metastasis can occur within few
months after diagnosis. The clinical
signs and symptoms of Ewing’s sarcoma appear when the tumor is in an
advanced stage, which limits treatment options and prognosis. Recently
chemotherapy and radiotherapy have
dramatically improved long-term survival rates. Surgery is justified only
if tumor control and preservation of
function are guaranteed.
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